Enhanced Expression of Glucose Transporter 1 on Erythrocyte Membrane in Hemodialysis Patients: The Possible Role in Erythrocyte Ascorbate Recycling

American Journal of Kidney Diseases

Volumn 47, Issue 6, 2006, Pages 1055-1063

  Wann, Joseph G ^{a,b,c,d,e,f,g,h}   Lin, Chien Sheng ^{a,b,c,d,e,f,g,h}   Chang, Li Chien ^{a,b,c,d,e,f,g,h}   Hsu, Yung Ho ^{a,b,c,d,e,f,g,h}   Chien, Chiang Ting ^{a,b,c,d,e,f,g,h}   Tai, Deborah W ^{a,b,c,d,e,f,g,h}   Chen, Jin Shuen ^{a,b,c,d,e,f,g,h}   Yang, Chih Ching ^{a,b,c,d,e,f,g,h}   Yeung, Lai King ^{a,b,c,d,e,f,g,h}   Chen, Chau Fong ^{a,b,c,d,e,f,g,h}  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

^h CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

Ascorbate; erythrocyte; glucose transporter 1; hemodialysis (HD)

Indexed keywords

ASCORBIC ACID; DEHYDROASCORBIC ACID; GLUCOSE TRANSPORTER 1;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ERYTHROCYTE MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECYCLING; UREMIA;

AGED; ASCORBIC ACID; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHALASIN B; DEHYDROASCORBIC ACID; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; UREMIA;

EID: 33646781312     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.02.190     Document Type: Article

References (43)

1. Frei B., Stocker R., and Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 85 (1988) 9748-9752
2. Frei B., England L., and Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 86 (1989) 6377-6381
3. Böhm V., Tiroke K., Schneider S., Sperschneider H., Stein G., and Bitsch R. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. Int J Vitam Nutr Res 67 (1997) 262-266
4. Hirano H., Tone Y., Otani H., et al. Levels of serum ascorbate and its metabolites in hemodialysis patients. Nippon Jinzo Gakkai Shi 46 (2004) 426-433
5. Morena M., Cristol J.P., Bosc J.Y., et al. Convective and diffusive losses of vitamin C during haemodiafiltration session. A contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 17 (2002) 422-427
6. Tetta C., Biasioli S., Schiavon R., et al. An overview of haemodialysis and oxidant stress. Blood Purif 17 (1999) 118-126
7. Becker B.N., Himmelfarb J., Henrich W.L., and Hakim R.M. Reassessing the cardiac risk profile in chronic hemodialysis patients. A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 8 (1997) 475-486
8. Dhariwal K.R., Hartzell W.O., and Levine M. Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr 54 (1991) 712-716
9. Okamura M. Uptake of l-ascorbic acid and l-dehydroascorbic acid by human erythrocytes and HeLa cells. J Nutr Sci Vitaminol (Tokyo) 25 (1979) 269-279
10. Washko P.W., Wang Y., and Levine M. Ascorbic acid recycling in human neutrophils. J Biol Chem 268 (1993) 15531-15535
11. May J.M., Qu Z.C., Whitesell R.R., and Cobb C.E. Ascorbate recycling in human erythrocytes. Role of GSH in reducing dehydroascorbate. Free Radic Biol Med 20 (1996) 543-551
12. 13C NMR studies of vitamin C transport and its redox cycling in human erythrocytes. Biochemistry 37 (1998) 7578-7588
13. VanDuijn M.M., Tijssen K., VanSteveninck J., Van Den Broek P.J., and Van Der Z.J. Erythrocytes reduce extracellular ascorbate free radicals using intracellular ascorbate as an electron donor. J Biol Chem 275 (2000) 27720-27725
14. Mendiratta S., Qu Z.C., and May J.M. Erythrocyte ascorbate recycling. Antioxidant effects in blood. Free Radic Biol Med 24 (1998) 789-797
15. May J.M., Qu Z.C., and Mendiratta S. Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys 349 (1998) 281-289
16. Mehlhorn R.J. Ascorbate- and dehydroascorbic acid-mediated reduction of free radicals in the human erythrocyte. J Biol Chem 266 (1991) 2724-2731
17. Nakayama H., Akiyama S., Inagaki M., Gotoh Y., and Oguchi K. Dehydroascorbic acid and oxidative stress in haemodialysis patients. Nephrol Dial Transplant 16 (2001) 574-579
18. Lykkesfeldt J., Loft S., Nielsen J.B., and Poulsen H.E. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 65 (1997) 959-963
19. VanDuijn M.M., Tijssen K., VanSteveninck J., Van Den Broek P.J., and Van Der Z.J. Erythrocytes reduce extracellular ascorbate free radicals using intracellular ascorbate as an electron donor. J Biol Chem 275 (2000) 27720-27725
20. Westerman M.P., Zhang Y., McConnell J.P., et al. Ascorbate levels in red blood cells and urine in patients with sickle cell anemia. Am J Hematol 65 (2000) 174-175
21. Evans R.M., Currie L., and Campbell A. The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. Br J Nutr 47 (1982) 473-482
22. Lykkesfeldt J., Loft S., and Poulsen H.E. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection-Are they reliable biomarkers of oxidative stress?. Anal Biochem 229 (1995) 329-335
23. Lunec J., and Blake D.R. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA). Free Radic Res Commun 1 (1985) 31-39
24. Nagy E., and Degrell I. Determination of ascorbic acid and dehydroascorbic acid in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection. J Chromatogr 497 (1989) 276-281
25. Dhariwal K.R., Hartzell W.O., and Levine M. Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr 54 (1991) 712-716
26. Capellmann M., Becka M., and Bolt H.M. A note on distribution of human plasma levels of ascorbic and dehydroascorbic acid. J Physiol Pharmacol 45 (1994) 183-187
27. Bakaev V.V., Efremov A.V., and Tityaev I.I. Low levels of dehydroascorbic acid in uraemic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis. Nephrol Dial Transplant 14 (1999) 1472-1474
28. Al-Ghamdi J.M., Al-Jafari A.A., Alhomida A.S., Sobki S.H., Al-Sulaiman M.H., and Al-Khader A.A. Whole blood total, reduced and oxidized ascorbic acid levels in Saudi patients with chronic renal failure. Influence of gender and chronic haemodialysis. Med Sci Res 26 (1998) 343-347
29. Song J.H., Shin S.H., and Ross G.M. Oxidative stress induced by ascorbate causes neuronal damage in an in vitro system. Brain Res 895 (2001) 66-72
30. Wilson J.X., Peters C.E., Sitar S.M., Daoust P., and Gelb A.W. Glutamate stimulates ascorbate transport by astrocytes. Brain Res 858 (2000) 61-66
31. Siushansian R., Dixon S.J., and Wilson J.X. Osmotic swelling stimulates ascorbate efflux from cerebral astrocytes. J Neurochem 66 (1996) 1227-1233
32. Daskalopoulos R., Korcok J., Tao L., and Wilson J.X. Accumulation of intracellular ascorbate from dehydroascorbic acid by astrocytes is decreased after oxidative stress and restored by propofol. Glia 39 (2002) 124-132
33. Vera J.C., Rivas C.I., Fischbarg J., and Golde D.W. Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature 364 (1993) 79-82
34. Bianchi J., and Rose R.C. Glucose-independent transport of dehydroascorbic acid in human erythrocytes. Proc Soc Exp Biol Med 181 (1986) 333-337
35. Goldenberg H., and Schweinzer E. Transport of vitamin C in animal and human cells. J Bioenerg Biomembr 26 (1994) 359-367
36. Root-Bernstein R., Busik J.V., and Henry D.N. Are diabetic neuropathy, retinopathy and nephropathy caused by hyperglycemic exclusion of dehydroascorbate uptake by glucose transporters?. J Theor Biol 216 (2002) 345-359
37. De Vivo D.C., Trifiletti R.R., Jacobson R.I., Ronen G.M., Behmand R.A., and Harik S.I. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325 (1991) 703-709
38. Ozcan A., Deveci M.S., Oztas E., et al. Prognostic value of GLUT-1 expression in ovarian surface epithelial tumors. A morphometric study. Anal Quant Cytol Histol 27 (2005) 181-186
39. Yasuda M., Ogane N., Hayashi H., et al. Glucose transporter-1 expression in the thyroid gland. Clinicopathological significance for papillary carcinoma. Oncol Rep 14 (2005) 1499-1504
40. Doki Y., Takachi K., Ishikawa O., et al. Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy. Surgery 137 (2005) 536-544
41. Hauptmann S., Grunewald V., Molls D., et al. Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation. Anticancer Res 25 (2005) 3431-3436
42. Padh H. Cellular functions of ascorbic acid. Biochem Cell Biol 68 (1990) 1166-1173
43. May J.M., Qu Z.C., and Whitesell R.R. Ascorbic acid recycling enhances the antioxidant reserve of human erythrocytes. Biochemistry 34 (1995) 12721-12728